Leading investors support Opsona
Opsona works closely with leading investors to maximise the potential of our biotechnology research.
Our financial partners include:
- Novartis Venture Fund
- Inventages Venture Capital
- Seroba Kernel Life Sciences
- Fountain Healthcare Partners
- Roche Venture Fund
- GenenFund
- Enterprise Ireland
Novartis Venture Fund
The Novartis Venture Fund, established in 1996 currently manages over $650 million in committed capital. NVF invests in companies which have the potential to change a core therapeutic field or explore new business areas that will be critical to patient care. Our primary interest is in the development of novel therapeutics and platforms as well as medical devices, diagnostics, and delivery systems. The Fund invests for financial objectives at all stages, but prefers to invest in the early-stages of company development. With eight investment professionals located in Basel, Switzerland and Cambridge, MA the team has extensive experience in pharmaceutical R&D and venture capital. Website: www.venturefund.novartis.com/
Inventages Venture Capital
Inventages is one of the world's largest life science, nutrition and wellness focused venture capital funds. It manages investments of $1.5 billion in companies around the world. Inventages supports the development of company strategies, executive recruitment, assisting with major financial transactions and providing access to a network of potential buyers.
Website: www.inventages.com
Seroba Kernel Life Sciences
Seroba Kernel is a dedicated life science venture capital fund manager with offices in Ireland and the UK. The firm recently announced the first close of Seroba Kernel Life Sciences Fund II with €75m in committed capital, bringing total funds under management by the six-member team in the life science sector to over €200m. The fund will invest in European life science companies with the majority of its capital invested in Ireland and the UK. Website: www.seroba-kernel.com
Fountain Healthcare Partners
Fountain Healthcare Partners ("Fountain") is a life science focused venture capital fund headquartered in Dublin, Ireland with a second office in New York, US. Fountain specialises in making investments in biotechnology, medical device, specialty pharma and diagnostic companies and allocates the majority of its capital to Europe with a primary emphasis on Ireland. Fountain launched its inaugural fund (Fountain Healthcare Partners I) in May 2008 with €75M in committed capital. Website: www.fh-partners.com
Roche Venture Fund
The Roche Venture Fund is the corporate venture fund of the healthcare company Roche. Roche has allocated CHF500 million to the fund that currently has a portfolio of around 30 companies located in 10 countries across Europe, North America and the Pacific region. Roche are committed to helping their portfolio companies develop innovative ideas and guidance towards a marketed product. As part of a multinational healthcare company, Roche Venture fund has access to considerable expertise both internally and externally. Roche co-invest with leading venture funds, including other corporate venture funds, on a regular basis. Website: www.venturefund.roche.com
GenenFund
GenenFund is the corporate Venture Capital arm of Genentech Inc. Founded more than 30 years ago, Genentech is a leading biotechnology company that discovers, develops, manufactures and commercialises medicines to treat patients with significant unmet medical needs. Genentech, is a member of the Roche Group & is headquartered in South San Francisco.
Website: www.gene.com/
Enterprise Ireland
Enterprise Ireland is the Irish government agency responsible for developing and promoting the indigenous business sector.
Its mission is to accelerate the development of world-class Irish companies to achieve strong positions in global markets.
Website: www.enterprise-ireland.com/
Read about our Partnering Opportunities